FI
Falin Ishwarlal Majmudar
About Falin Ishwarlal Majmudar
Data last updated:
Falin Ishwarlal Majmudar is a Whole-Time Director at Novartis India Limited (since 2024). The company operates in Pharma. Novartis India Limited reported revenue of ₹398 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novartis India Limited L24200MH1947PLC006104 | Whole-Time Director | 28 Jun 2024 | 1947 | ₹398 Cr (FY 2025) | Active |
Board colleagues of Falin Ishwarlal Majmudar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandni Bhupendra Maru | Novartis India Limited | Company Secretary | |
| Christopher David Snook | 00369790 | Novartis India Limited | Director |
| Gira Jagdeesh Sardesai | 02610502 | Novartis India Limited | Director |
| Gowree Ashish Gokhale | 09351661 | Novartis India Limited | Director |
| Sanker Parameswaran | 00008187 | Novartis India Limited | Director |
| Shilpa Shashank Joshi | 09775615 | Novartis India Limited | Whole-Time Director |
| Shilpa Shashank Joshi | Novartis India Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Falin Ishwarlal Majmudar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Falin Ishwarlal Majmudar
Falin Ishwarlal Majmudar currently holds 1 directorship: Novartis India Limited (Whole-Time Director, since 28 Jun 2024, revenue ₹398 Cr (FY 2025)).
Falin Ishwarlal Majmudar was first appointed on 28 Jun 2024 as Whole-Time Director at Novartis India Limited.
The current boards of Falin Ishwarlal Majmudar's companies include Chandni Bhupendra Maru (Novartis India Limited), Christopher David Snook (Novartis India Limited), Gira Jagdeesh Sardesai (Novartis India Limited), Gowree Ashish Gokhale (Novartis India Limited), Sanker Parameswaran (Novartis India Limited), Shilpa Shashank Joshi (Novartis India Limited), among others.